Peace Over Promise

March 12, 2019
Be the first to like.


The drug edaravone, under the brand name Radicava, was lauded as a minor miraclewhen it was approved in the U.S. in May 2017. It was the first new medication in 22 years to help treat the neurodegenerative disease. It has also been approved in Japan and South Korea.

Questions by some doctors, patients and advocates have come faster than answers, however.

The Post-Dispatch wrote about Frei when he started the taking the drug in November 2017. After a year of receiving the infusions 10 out of every 28 days, Frei took half the doses in November and December before deciding to quit.

…continue reading ‘Peace Over Promise’

Thumb image via St. Louis Post-Dispatch/Laurie Skrivan

Be the first to like.

StL Post-Dispatch

Tags: , , , , , , , , , , , , , ,

Leave a Reply